Neidio i’r brif dudalen lywio Neidio i chwilio Neidio i’r prif gynnwys

Methodological consensus on clinical proton MRS of the brain: Review and recommendations

  • Martin Wilson
  • , Ovidiu Andronesi
  • , Peter B Barker
  • , Robert Bartha
  • , Alberto Bizzi
  • , Patrick J Bolan
  • , Kevin M Brindle
  • , In-Young Choi
  • , Cristina Cudalbu
  • , Ulrike Dydak
  • , Uzay E Emir
  • , Ramon G Gonzalez
  • , Stephan Gruber
  • , Rolf Gruetter
  • , Rakesh K Gupta
  • , Arend Heerschap
  • , Anke Henning
  • , Hoby P Hetherington
  • , Petra S Huppi
  • , Ralph E Hurd
  • Kejal Kantarci, Risto A Kauppinen, Dennis W J Klomp, Roland Kreis, Marijn J Kruiskamp, Martin O Leach, Alexander P Lin, Peter R Luijten, Małgorzata Marjańska, Andrew A Maudsley, Dieter J Meyerhoff, Carolyn E Mountford, Paul G Mullins, James B Murdoch, Sarah J Nelson, Ralph Noeske, Gülin Öz, Julie W Pan, Andrew C Peet, Harish Poptani, Stefan Posse, Eva-Maria Ratai, Nouha Salibi, Tom W J Scheenen, Ian C P Smith, Brian J Soher, Ivan Tkáč, Daniel B Vigneron, Franklyn A Howe
    • UOC Neuroradiologia, Istituto Neurologico Carlo Besta, Milano
    • Fortis Memorial Research Institute, Gurugram, Haryana, India.
    • Max Planck Institute for Biological Cybernetics, Tuebingen
    • Stanford Radiological Sciences Lab, Stanford, California.
    • Department of Radiology, Mayo Clinic, Rochester, Minnesota.
    • University of Bristol
    • University Medical Centre, Utrecht
    • Philips N.V.
    • Royal Marsden Hospital
    • Translational Research Institute, Woolloongabba
    • Canon Medical Research USA, Mayfield Village, Ohio.
    • GE Healthcare, Berlin
    • MR R&D, Siemens Healthineers, Malvern, Pennsylvania.
    • Innovative Biodiagnostics, Winnipeg, Canada.
    • School of Sport and Exercise Sciences, University of Birmingham
    • Harvard Medical School, Boston
    • Johns Hopkins University
    • University of Western Ontario, Canada
    • University of Minnesota, USA
    • Institute of Criminology, University of Cambridge, Cambridge
    • Purdue University
    • University of Kansas Medical Centre
    • University of Vienna
    • École Polytechnique Fédérale de Lausanne
    • University of Bern
    • University of Pittsburg
    • University of California, San Francisco
    • Department of Molecular and Clinical Pharmacology, University of Liverpool
    • University of Pittsburgh, PA
    • The University of New Mexico
    • Radboud University Medical Center
    • University of Miami
    • St George's University of London
    • University of Geneva, Geneva, Switzerland
    • Duke University

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl adolygu › adolygiad gan gymheiriaid

    407 Wedi eu Llwytho i Lawr (Pure)

    Crynodeb

    Proton MRS (1 H MRS) provides noninvasive, quantitative metabolite profiles of tissue and has been shown to aid the clinical management of several brain diseases. Although most modern clinical MR scanners support MRS capabilities, routine use is largely restricted to specialized centers with good access to MR research support. Widespread adoption has been slow for several reasons, and technical challenges toward obtaining reliable good-quality results have been identified as a contributing factor. Considerable progress has been made by the research community to address many of these challenges, and in this paper a consensus is presented on deficiencies in widely available MRS methodology and validated improvements that are currently in routine use at several clinical research institutions. In particular, the localization error for the PRESS localization sequence was found to be unacceptably high at 3 T, and use of the semi-adiabatic localization by adiabatic selective refocusing sequence is a recommended solution. Incorporation of simulated metabolite basis sets into analysis routines is recommended for reliably capturing the full spectral detail available from short TE acquisitions. In addition, the importance of achieving a highly homogenous static magnetic field (B0 ) in the acquisition region is emphasized, and the limitations of current methods and hardware are discussed. Most recommendations require only software improvements, greatly enhancing the capabilities of clinical MRS on existing hardware. Implementation of these recommendations should strengthen current clinical applications and advance progress toward developing and validating new MRS biomarkers for clinical use.

    Iaith wreiddiolSaesneg
    Tudalennau (o-i)527-550
    Nifer y tudalennau24
    CyfnodolynMagnetic Resonance in Medicine
    Cyfrol82
    Rhif cyhoeddi2
    Dyddiad ar-lein cynnar28 Maw 2019
    Dynodwyr Gwrthrych Digidol (DOIs)
    StatwsCyhoeddwyd - Awst 2019

    Ôl bys

    Gweld gwybodaeth am bynciau ymchwil 'Methodological consensus on clinical proton MRS of the brain: Review and recommendations'. Gyda’i gilydd, maen nhw’n ffurfio ôl bys unigryw.

    Dyfynnu hyn